Bradley M. Turner

Napsin A, a New Marker for Lung Adenocarcinoma, Is Complementary and More Sensitive and Specific Than Thyroid Transcription Factor 1 in the Differential Diagnosis of Primary Pulmonary Carcinoma: Evaluation of 1674 Cases by Tissue Microarray

Bradley M. Turner, Philip T. Cagle, Irma M. Sáinz et al. · Archives of Pathology & Laboratory Medicine · 2012 · 230 citations · Full text

HER2-low breast cancers: incidence, HER2 staining patterns, clinicopathologic features, MammaPrint and BluePrint genomic profiles

Huina Zhang, Hani Katerji, Bradley M. Turner et al. · Modern Pathology · 2022 · 105 citations

Her2-low Breast Cancers, Breast Oncology, Blueprint Genomic Profiles +10

Use of modified Magee equations and histologic criteria to predict the Oncotype DX recurrence score

Bradley M. Turner, Kristin A. Skinner, Ping Tang et al. · Modern Pathology · 2015 · 80 citations · Full text

Biostatistics, Modified Magee Equations, Histologic Criteria

Interobserver and Interantibody Reproducibility of HER2 Immunohistochemical Scoring in an Enriched HER2-Low–Expressing Breast Cancer Cohort

Cansu Karakaş, Haley Tyburski, Bradley M. Turner et al. · American Journal of Clinical Pathology · 2023 · 56 citations · Full text

Optimizing the Use of Gene Expression Profiling in Early-Stage Breast Cancer

Hyun-seok Kim, Christopher B. Umbricht, Peter B. Illei et al. · Journal of Clinical Oncology · 2016 · 55 citations · Full text

Breast Oncology, Pathology, Transcriptomics Technology +19